No recent analyst price targets found for NLTX.
Latest News for NLTX
Neoleukin Therapeutics (NASDAQ:NLTX) & Zymeworks (NASDAQ:ZYME) Critical Contrast
Neoleukin Therapeutics (NASDAQ: NLTX - Get Free Report) and Zymeworks (NASDAQ: ZYME - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Institutional and Insider Ownership 52.4% of Neoleukin Therapeutics
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NLTX.
U.S. House Trading
No House trades found for NLTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.